NCT06862570View on ClinicalTrials.gov

Assessment of Local Anaesthesia Effectiveness in Symptomatic Irreversible Pulpitis

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
Symptomatic Irreversible Pulpitis
Interventions
DRUG

2% lignocaine with epinephrine 1.8 ml(36mg/ml lignocaine HCL, epinephrine bitartrate 0.0324mg/ml)

2% lignocaine with epinephrine 1.8 ml(36mg/ml lignocaine HCL, epinephrine bitartrate 0.0324mg/ml)

DRUG

4% Articaine with epinephrine 1.7 ml (40mg/ml Articaine HCL, epinephrine bitartrate 0.018 mg/ml)

4% Articaine with epinephrine 1.7 ml (40mg/ml Articaine HCL, epinephrine bitartrate 0.018 mg/ml)

Trial Locations (1)

042

Zahra Zubir, Lahore

All Listed Sponsors
lead

28 Military Dental Centre Lahore

OTHER_GOV